RadiusXR, Glaukos, and Topcon Healthcare Launch Inspire® Visual Field Solution
Topcon Healthcare, RadiusXR, and Glaukos Corporation (NYSE: GKOS) have announced a new collaboration, unveiling RadiusXR’s next-generation wearable vision testing platform, Inspire®. This partnership combines RadiusXR’s innovative visual field technology with Topcon Healthcare’s expertise in robotic diagnostics and digital healthcare solutions, alongside Glaukos’ dedication to expanding patient access by making ophthalmic disease diagnoses, including glaucoma, more accessible. The goal of this collaboration is to broaden access to visual field exams, ensuring that all glaucoma patients receive the crucial testing and education they need.
RadiusXR has introduced the Inspire platform, the only commercially available wearable vision diagnostic system that combines visual field testing with proven performance, onboard patient education, and data-driven intelligence to enhance clinical decision-making. Weighing just six ounces, Inspire is purpose-built for future expansion, offering more than just traditional diagnostics by supporting testing for chronic and systemic conditions beyond vision.
The collaboration between RadiusXR, Topcon Healthcare, and Glaukos Corporation is set to transform healthcare, integrating innovative diagnostic and therapeutic solutions. Ali Tafreshi, CEO and President of Topcon Healthcare, said, “By combining the new Inspire wearable platform’s data with our robotic diagnostics on the Harmony digital health information platform, we’re advancing our Healthcare from the Eye initiative, creating a dynamic, integrated digital healthcare ecosystem.”
This partnership allows Topcon Healthcare to become the exclusive global distributor of the Inspire platform, expanding the wearable diagnostic footprint. Topcon, along with RadiusXR and Glaukos, will collaborate on commercialization, research, and education efforts. Furthermore, Glaukos and Topcon will work together to advance patient engagement, education, and the broader digital eyecare ecosystem.
Thomas Burns, Chairman and CEO of Glaukos, stated, “We’re thrilled to partner with Topcon Healthcare to drive commercialization efforts for RadiusXR’s technology, ensuring that the Inspire platform reaches more patients. This collaboration supports our mission to advance the standard of care in glaucoma and improve patient outcomes by democratizing visual field testing and providing digital tools that enable better patient care worldwide.”
The launch of Inspire marks a powerful collaboration between RadiusXR, Topcon Healthcare, and Glaukos, bringing together their expertise to accelerate the advancement of vision diagnostics. By integrating wearable vision testing with advanced ophthalmic imaging and AI-powered data analysis, the collaboration aims to expand access to high-quality eye care, enabling earlier disease detection and driving smarter diagnostics.
Ammad Khan, CEO of RadiusXR, emphasized the company’s mission: “RadiusXR was founded to transform digital health, and the launch of Inspire is a testament to that commitment. By combining our wearable platform with Topcon Healthcare’s imaging solutions and Glaukos’ focus on patient engagement, we are creating a connected diagnostic ecosystem that empowers clinicians and expands access to critical vision care.”
About the Companies:
Topcon Healthcare
Topcon Healthcare, part of Topcon Corporation, is a leading provider of digital healthcare solutions, committed to improving access to quality healthcare while reducing costs. Their vision, “Healthcare from the Eye™,” applies AI models to imaging data from the eye to enable early disease detection and better management. Powered by Harmony®, their cloud-based digital health information platform, Topcon Healthcare facilitates a connected care ecosystem.
RadiusXR
RadiusXR is a digital healthcare technology company focused on solving complex healthcare issues. The company’s goal is to transform vision testing and eye care with an advanced digital platform that improves patient access, streamlines operations, and boosts confidence in care delivery. Through innovative wearable technologies, RadiusXR is disrupting the healthcare status quo and continues to develop groundbreaking solutions to improve patient care.
Glaukos
Glaukos is a leader in ophthalmic pharmaceutical and medical technology, committed to developing novel therapies for glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to traditional glaucoma treatments. Glaukos recently launched iDose® TR, a long-duration intracameral pharmaceutical designed for 24/7 glaucoma drug delivery. The company also offers FDA-approved corneal cross-linking therapy for keratoconus, a rare corneal disorder. Glaukos continues to innovate with a robust pipeline of dropless technologies designed to advance the standard of care for chronic eye diseases.
The Impact of Inspire
Inspire’s wearable vision testing technology offers patients and clinicians a portable, real-time diagnostic tool that fits seamlessly into modern healthcare systems. The integration of the platform with Topcon’s advanced imaging solutions and Glaukos’ patient-centric approach is set to provide more efficient, accessible, and effective glaucoma care. The wearable system not only helps detect glaucoma earlier but also offers crucial data to drive better clinical decision-making, improving outcomes for patients suffering from chronic eye diseases.
This collaboration represents a major step toward creating a more integrated, personalized approach to eye care, with the potential to revolutionize how vision and chronic conditions are diagnosed and treated. By broadening access to these advanced diagnostic tools, RadiusXR, Topcon, and Glaukos are paving the way for a future where high-quality, data-driven care is available to all patients, regardless of location or resources.
